JP2018520999A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520999A5
JP2018520999A5 JP2017559043A JP2017559043A JP2018520999A5 JP 2018520999 A5 JP2018520999 A5 JP 2018520999A5 JP 2017559043 A JP2017559043 A JP 2017559043A JP 2017559043 A JP2017559043 A JP 2017559043A JP 2018520999 A5 JP2018520999 A5 JP 2018520999A5
Authority
JP
Japan
Prior art keywords
lys
asp
dval
dala
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017559043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520999A (ja
JP7372026B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/026966 external-priority patent/WO2016182660A1/en
Publication of JP2018520999A publication Critical patent/JP2018520999A/ja
Publication of JP2018520999A5 publication Critical patent/JP2018520999A5/ja
Application granted granted Critical
Publication of JP7372026B2 publication Critical patent/JP7372026B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017559043A 2015-05-12 2016-04-11 炎症および線維症のペプチド治療 Active JP7372026B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562160173P 2015-05-12 2015-05-12
US62/160,173 2015-05-12
PCT/US2016/026966 WO2016182660A1 (en) 2015-05-12 2016-04-11 Peptide treatment for inflammation and fibrosis

Publications (3)

Publication Number Publication Date
JP2018520999A JP2018520999A (ja) 2018-08-02
JP2018520999A5 true JP2018520999A5 (cg-RX-API-DMAC7.html) 2021-02-25
JP7372026B2 JP7372026B2 (ja) 2023-10-31

Family

ID=57248348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017559043A Active JP7372026B2 (ja) 2015-05-12 2016-04-11 炎症および線維症のペプチド治療

Country Status (7)

Country Link
US (1) US10434134B2 (cg-RX-API-DMAC7.html)
EP (1) EP3294752B1 (cg-RX-API-DMAC7.html)
JP (1) JP7372026B2 (cg-RX-API-DMAC7.html)
CN (3) CN114181281A (cg-RX-API-DMAC7.html)
AU (1) AU2016260190A1 (cg-RX-API-DMAC7.html)
CA (1) CA2984769C (cg-RX-API-DMAC7.html)
WO (1) WO2016182660A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114181281A (zh) * 2015-05-12 2022-03-15 加利福尼亚大学董事会 用于炎症和纤维化的肽治疗
WO2018126009A1 (en) * 2016-12-29 2018-07-05 University Of Miami Method for modulating inflammasome activity and inflammation in the lung
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation
EP3818081A4 (en) 2018-07-03 2022-06-22 University of Miami COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME-RELATED DISEASES OR DISORDERS
CN113301914B (zh) * 2018-10-25 2026-02-03 尼希尔有限公司 用于治疗和预防纤维化的组合物和方法
CN111770539B (zh) * 2019-04-02 2021-07-09 大唐移动通信设备有限公司 一种lmf选择方法、终端定位服务方法及装置
WO2021101966A1 (en) * 2019-11-18 2021-05-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of fibrosis with combined blockade of il-6 and immune checkpoint
CN114134191B (zh) * 2020-09-04 2023-12-12 琛蓝(美国)营养制品股份有限公司 一种抗炎护肾的蛤蜊肽的制备方法和应用
CN112960780B (zh) * 2021-03-03 2023-02-03 龙江环保集团股份有限公司 一种生物膜载体的预处理方法及生物法污水处理工艺
DE102022203153A1 (de) 2022-03-31 2023-10-05 Psa Automobiles Sa Stauraumanordnung für einen Innenraum eines Fahrzeugs, Fahrzeug mit der Stauraumanordnung und Verfahren zur Benutzung einer Stauraumanordnung
KR102772405B1 (ko) * 2022-06-10 2025-02-26 (주)케어젠 근육 손실 저해 및 근육량 증진 활성을 갖는 펩타이드 및 이의 용도
CN115850440B (zh) * 2022-12-09 2023-07-11 中国人民解放军陆军军医大学 一种长链MyD88诱饵肽及其作为药物的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002054938A2 (en) * 2000-10-27 2002-07-18 The Regents Of The University Of California Treatment of disease by inducing cell apoptosis
US8129349B2 (en) 2000-10-27 2012-03-06 The Regents Of The University Of California Treatment of disease by inducing cell apoptosis
US7402567B2 (en) * 2000-10-27 2008-07-22 The Regents Of The University Of California Treatment of disease by inducing cell apoptosis
CN1678336A (zh) * 2002-02-21 2005-10-05 加州大学校务委员会 用细胞凋亡诱导方法治疗疾病
US7119071B2 (en) * 2002-05-21 2006-10-10 University Of Medicine And Dentistry Of New Jersey Amino terminal substance P compositions and methods for using the same
CN101227918A (zh) * 2005-04-29 2008-07-23 加州大学评议会 治疗以炎症反应为特征的病理的肽和肽模拟物
AU2006242651B2 (en) * 2005-04-29 2013-05-16 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US8865657B2 (en) * 2005-08-19 2014-10-21 New York University Compositions and methods for inactivating or suppressing inflammatory cells
EP2324048A2 (en) * 2008-07-30 2011-05-25 Cosmix Therapeutics Llc Peptide therapeutics that bind vegf and methods of use thereof
WO2013013085A2 (en) * 2011-07-19 2013-01-24 Thrasos Innovation, Inc. Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis
JP6562632B2 (ja) * 2012-02-14 2019-08-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心血管疾患および他の状態のためのパラクリン遺伝子の全身送達および制御された発現
CN114181281A (zh) * 2015-05-12 2022-03-15 加利福尼亚大学董事会 用于炎症和纤维化的肽治疗

Similar Documents

Publication Publication Date Title
IL275188B1 (en) Use of cyclic tripeptide to improve cellular energy metabolism
JP5882260B2 (ja) ペプチドおよびその使用
KR101965467B1 (ko) 아드레노메둘린의 폴리에틸렌 글리콜 기반 전구약물 및 그의 용도
JP2015533833A5 (cg-RX-API-DMAC7.html)
RU2019134382A (ru) Лекарственное средство для лечения фиброзного заболевания
RU2010114034A (ru) Терапевтическое применение нейропептида ei и acth 7-38 и их комбинаций
HRP20201081T1 (hr) Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe
CA2595801A1 (en) Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
IL316406A (en) Lipid-modified relaxin B peptide chains and their medical use
JP2012115277A5 (cg-RX-API-DMAC7.html)
JP2019513752A5 (cg-RX-API-DMAC7.html)
JP2015509950A5 (cg-RX-API-DMAC7.html)
JP2016529306A5 (cg-RX-API-DMAC7.html)
MX2022003057A (es) Nuevos peptidos.
HRP20221046T1 (hr) Beta-ukosni peptidomimetici kao selektivni inhibitori elastaze
JP2013529916A5 (cg-RX-API-DMAC7.html)
CN116421704A (zh) 多肽pd-dp-005在制备治疗肺部疾病药物中的应用及其药物
CN104039793A (zh) 二氢吡咯并[1,2-c]咪唑基醛固酮合成酶或芳香酶抑制剂的新形式及盐
JP2017522350A5 (cg-RX-API-DMAC7.html)
JP2023503380A5 (cg-RX-API-DMAC7.html)
JP2010083896A5 (cg-RX-API-DMAC7.html)
JP2013512226A5 (cg-RX-API-DMAC7.html)
JP2803477B2 (ja) ヘキサペプチド
EP2832357A1 (en) Selective AT2 receptor agonists for use in treatment of cachexia
CR20250156A (es) DERIVADOS DE BENZIMIDAZOL CÍCLICO COMO INHIBIDORES DE cGAS